Latest filing published 31 Dec 2009 for Navidea Biopharmaceuticals, INC., €10k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
J. Frank Whitley: trading record in brief
This profile gathers the share dealings of J. Frank Whitley in Navidea Biopharmaceuticals, Inc. Between 3 July 2007 and 30 December 2009, the trades on record add up to 4 filings.
Purchases make up the whole of the open-market record (2 purchases, €13k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise. So far in 2009, the count stands at 1 purchase and no sales.
The newest entry dates from 31 December 2009: an option exercise of €10k, in Navidea Biopharmaceuticals, Inc. The most recent open-market purchase was published on 30 March 2009, 6,433 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to J. Frank Whitley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ US$0.50Common StockSEC:0001225208-09-025201:0
- 10,000 shares@ US$0.53Common StockSEC:0001225208-09-008566:0Canonical exit: 24 Jun 2009 (T+90)
- 20,000 shares@ US$0.65Common StockSEC:0001225208-08-013824:0Canonical exit: 13 Nov 2008 (T+90)
- 500 shares0Common StockSEC:0000949265-08-000054:0
4 of 4 declarations